Drugs / TJ-68
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04998305 | Sep 2022 → Jul 2024 | amyotrophic lateral sclerosis | Hiroshi Mitsumoto | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TJ-68 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04998305 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “TJ-68, also known as Shakuyakukanzoto - a kampo, herbal medicine -” NCT04998305 ↗ |
| Route | Oral | “participants will take 2.5 g of TJ-68 for three times per day before meals.” NCT04998305 ↗ |